A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment
✍ Scribed by Christopher J. Sweeney; Chris Takimoto; Leslie Wood; Jennifer M. Porter; William G. Tracewell; Mona Darwish; Denise M. D’Andrea; Scot C. Remick
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 289 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The pharmacokinetics of the beta 1-selective adrenergic antagonist (R,S)-celiprolol has been studied after oral administration of 200 mg celiprolol-HCl to 8 healthy volunteers and 8 patients with various degrees of impaired renal function. No significant difference was found between the two enantiom
The pharmacokinetics of midazolam, a water soluble 1,4-benzodiazepine, has been studied in 12 patients (11 male, 1 female; age range 19-57 years) with epilepsy. All patients were taking hepatic enzyme inducing antiepileptic drugs (AEDs) on a regular basis. Midazolam (5 mg) was administered intraveno